Withdrawal of Immunosuppression in Recipients of Face and Extremity Transplants

NCT01853111 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Vascularized Composite Allotransplantation

Interventions

BIOLOGICAL: Interleukin-2

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]